This site is updated Hourly Every Day

Trending Featured Popular Today, Right Now

Colorado's Only Reliable Source for Daily News @ Marijuana, Psychedelics & more...

Post: Arizona on the Brink of Revolutionizing PTSD Treatment for First Responders with MDMA Therapy

Picture of Anschutz Medical Campus

Anschutz Medical Campus

AnschutzMedicalCampus.com is an independent website not associated or affiliated with CU Anschutz Medical Campus, CU, or Fitzsimons innovation campus.

Recent Posts

Anschutz Medical Campus

Arizona on the Brink of Revolutionizing PTSD Treatment for First Responders with MDMA Therapy
Facebook
X
LinkedIn
WhatsApp
Telegram
Threads
Email

Source: Gage Skidmore , CC BY 2.0 , via Wikimedia Commons

In a groundbreaking shift toward unconventional therapies for first responders grappling with PTSD, Arizona could soon green-light the use of MDMA-assisted therapy, pending federal approval. This therapy, potentially covered by worker’s compensation, hinges on the impending decision by the Food and Drug Administration which, despite a recommendation against approval on June 4, will cast another vote next month on the matter, as reported by AZPM .

Last month, Gov. Katie Hobbs signed legislation to include MDMA therapy for first responders suffering from PTSD in Arizona’s worker’s comp plan, dependent on, the FDA’s stance. MDMA, also known as ecstasy or molly has properties that can aid in patient introspection during therapy, making it a promising tool for some clinicians and advocates who are pushing for its regulated therapeutic use. Advocates like Jonathan Lubecky, a military veteran who benefited from the therapy during a clinical trial, are vocal about the urgency of granting access. Lubecky told AZPM , “The question is, will it be August or will it be two to five years from now? It’s up to the FDA how many people die before it’s approved.”

The treatment involves combining MDMA with talk therapy, leveraging the drug’s ability to elevate self-awareness and reduce resistance to revisiting traumatic memories. Lykos Therapeutics, which submitted the application for MDMA-assisted therapy to the FDA, highlighted the results of two clinical trials. These showed promising outcomes, with 71% of those treated with MDMA no longer meeting PTSD criteria, in stark contrast to the 48% efficacy rate in the placebo group.

Stephanie Miller, a clinical therapist who treats patients in Arizona and Texas virtually, referred to other treatments such as ketamine, also controversial but increasingly popular among first responders. According to her practice, about half of the first responders she treats have received ketamine treatment. However, as Miller noted in an irony not lost on her, "MDMA and ketamine are the same things they’re arresting people for on the street.” This reality raises concerns, and perhaps even hesitations, among law enforcement officials considering such treatment options, she conveyed to […]

Leave a Reply

Your email address will not be published. Required fields are marked *

You Might Be Interested...